搜索范围
文件类型
61-73-4
应用筛选条件
关键词:'61-73-4'
显示 1-30 #N/A 381 条结果 关于 "61-73-4" 范围 技术文档
User Manual: TLC Explorer Documentation System
尽管轨迹基线是轨迹的(h)Rf测量的起点，绘制图形时会自动减去密度图基线，或者在设置补偿值后手动进行补偿。
11 术语表
11
73版本1.0 – 2024/02
1
2
3
4
5
6
7
8
9
10
11
（外部）电源 USB-C电源装置/
SMC®Plate Washer Evaluation Kit
75 72 65 63 64 62 61 62 53 68 54 77 65 7 11
E 68 53 69 63 68 62 58 59 64 61 60 81 64 7 11
F 76 63 73 83 73 70
Product Information Sheet - S9751
Metab.Rev., 36(3-4), 823-843
(2004).
2. Mueller, J.W. et al., Endocr. Rev., 36(5), 526-563
(2015).
3. Dodgson, K.S., and Powell, G.M., Biochem. J.,
73(4), 666-671 (1959).
4. Dodgson, K.S.
Glasgow's Minimum Essential Medium (GMEM) Product Information
0.03129
3 L-Glutamine 56-85-9 0.29200
4 L-Histidine hydrochloride
monohydrate
5934-29-2 0.02100
5 L-Isoleucine 73-32-5 0.05240
6 L-Leucine 61-90-5 0.05240
7 L-Lysine hydrochloride 657
Plant Growth
IAA-L-Asp)
CAS No. 2456-73-7
Plant cell culture, tested
Indole-3-butyric acid
(IBA; 4-(3-Indolyl)butanoic acid)
1 g
5 g
25 g
I 5386
E
N
Indole-3-butyric acid
(4-(3-Indolyl)butyric acid
Quality Control Ranges: MILLIPLEX® MAP Mouse High Sensitivity T Cell Magnetic Bead Panel
Control 2 73 – 153 pg/mL
IL-4 Control 1 2.9 – 6.0 pg/mL KC Control 1 33 – 69 pg/mL
Control 2 12 – 25
CHEMISCREEN MEMBRANE PREPARATION RECOMBINANT HUMAN LPA1 LYSOPHOSPHOLIPID RECEPTOR
The
membrane preparations exhibits EC50 of 73 nM for LPA in a GTPγS binding assay.
APPLICATIONS:
GTPγS Binding Assay
-9 -8 -7 -6 -5 -4
0
App Note: Analysis of Drugs of Abuse in Urine After Cleanup with New Supel™ Swift HLB Solid Phase Extraction 96-well Plates
Meperidine-D4 3.98 525.2 224.3 51 29 9 4
(±)-Methadone-D9 4.95 319.2 268.2 31 19 4 4
Oxycodone-D3 2.83 319.3 244.1 61 38 8 3
Oxymorphone-D3 1.73 305.1 287.2 46 23 5.5 4
cis-Tramadol-13C, D3
Product Information Sheet -b20223
cellular and molecular physiology, 310 (9):
L796-801(2016)
13. Ning Li, Front Immunol. 4 (61), 2013
14. Stenn K S, J Invest dermatol, 93(2):
287-290 (1989)
Notice
We provide information
Product Information Sheet -B20221
cellular and molecular
physiology, 310 (9): L796-801 (2016)
15. Ning Li, Front Immunol. 4 (61), 2013
Notice
We provide information and advice to our customers
on application technologies
363 - Separation of Phospholipids
FFA) 89
Phosphatidic acid (PA) 73
Phosphatidylethanolamine (PE) 61
Phosphatidylinositol (PI) 54
Phosphatidylcholine (PC) 14
Lysophosphatidylcholine (LPC) 4
Merck Millipore is a division
Product Information Dulbecco’s Modified Eagle’s Medium (DMEM)
L-Cystine 56-89-3 0.0480
3 Glycine 56-40-6 0.0300
4 L-Histidine hydrochloride monohydrate 5934-29-2 0.0420
5 L-Isoleucine 73-32-5 0.1050
6 L-Leucine 61-90-5 0.1050
7 L-Lysine hydrochloride 657-27-2 0.1460
The Effective Use of Protein Kinase Inhibitors
92 99 93 89 92 100 91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88
RABBIT ANTI-NEUROLIGIN 4 AFFNITY PURIFIED POLYCLONAL ANTIBODY
Canada • Phone: +1(800) 437-7500 • Fax: +1 (951) 676-9209 • Australia +61 3 9839 2000
www.millipore.com
RABBIT ANTI-NEUROLIGIN 4
AFFNITY PURIFIED
POLYCLONAL ANTIBODY
CATALOG NUMBER: AB15516
Data Sheet 1.15525.0001
(1985). Zählung coliformer Bakterien in Milch und
Milchprodukten (Internationaler Standard FIL-IDF 73).
Internationaler Milchwirtschaftsverband (1992). Milch und Milchprodukte - Vorbereitung
der Untersuchungsproben
Quick Start Guide-mPAGE® Color Protein Standard
242
140
116
83
58
49
30
24
14
10
kDa
259
154
123
87
61
50
32
26
15
10
kDa
275
151
121
86
61
50
32
26
15
10
kDa
288
165
129
91
63
50
RABBIT ANTI- CYP450 2E1 POLYCLONAL ANTIBODY
cytochromes P450 2E1, 2A, and
2B in the mouse ovary: the effect of 4-vinylcyclohexene and its diepoxide metabolite.
Toxicol Sci 73: 423-30.
Important Note: During shipment, small volumes of
Product Information Sheet - S9626
Metab.Rev., 36(3-4),
823-843 (2004).
2. Mueller, J.W. et al., Endocr. Rev., 36(5), 526-563
(2015).
3. Dodgson, K.S. and Powell, G.M., Biochem. J.,
73(4), 666-671 (1959).
4. Dodgson, K.S.
Medium 199 Modified
)
73:1.
2. Morgan, J. F., Campbell, M. E., Morton, H. J., JNCI (1955)
16:557.
3. Rutzky, L. P. and Pumper, R. W., In Vitrol (1974) 9:468.
4. Morton, H. J. and Toinai, S., TCA Manual (1978) 4:729.
Quality Control Range Sheet- PLX11-101 and PLX11-201
351 pg/mL Control 2 2962 - 6152 pg/ml
IL-10 Control 1 15 - 31 pg/mL
Control 2 73 - 152 pg/mL
Medium 199 Modified
)
73:1.
2. Morgan, J. F., Campbell, M. E., Morton, H. J., JNCI (1955)
16:557.
3. Rutzky, L. P. and Pumper, R. W., In Vitrol (1974) 9:468.
4. Morton, H. J. and Toinai, S., TCA Manual (1978) 4:729.
The Effective Use of Protein Kinase Inhibitors
92 99 93 89 92 100 91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88
Poster: A broad activity screen in support of a chemogenomic map for kinase signaling research and drug discovery
other kinases
A.
1 13 25 37 49 61 73 85 97 10
9
12
1
13
3
14
5
15
7
16
9
18
1
19
3
20
5
21
7
22
9
kinase
1 13
Data Sheet - MAB1637
Cells Dev. 14(4): 408-414.
Rieske, P. et al. (2005). Human fibroblast-derived cell lines have characteristics of embryonic stem
cells and cells of neuro-ectodermal origin. Differentiation 73(9-10): 474
PRECISIONTM MEMBRANE PREPARATION RECOMBINANT hERG POTASSIUM ION CHANNEL
Ackerman MJ et al. (1998) The long QT syndrome: ion channel diseases of the heart. Mayo
Clin. Proc. 73: 250-269.
Chiu PJS et al. (2004) Validation of a [3H]-Astemizole Binding Assay in HEK293 Cells
Product information sheet
("Hydrolysis"), pp. 417-447 (1971).
9. Morton, R.K., Biochem. J., 61(2), 232-240
(1955).
10. Morton, R.K., Biochem. J., 61(2), 240-244
(1955).
11. Harlow, E., and Lane, D., Antibodies:
Medium 199 Modified
)
73:1.
2. Morgan, J. F., Campbell, M. E., Morton, H. J., JNCI (1955)
16:557.
3. Rutzky, L. P. and Pumper, R. W., In Vitrol (1974) 9:468.
4. Morton, H. J. and Toinai, S., TCA Manual (1978) 4:729.
Data Sheet - G0407
Souza, L., et al., Science, 232, 61 (1986).
2. Nagata, S., et al., Nature, 319, 415-418 (1986).
3. Mazur, E., and Cohen J., Clin. Pharmacol. Ther.,
46, 250 (1989).
4. Morstyn, G., and Burgess, A., Cancer
Data Sheet - C5788
activation of an
inhibitory G-protein and the rearrangement of the
actin cytoskeleton. Neuroscience, 73, 1091-1107
(1996).
3. Wyatt, T.A., et al., Protein kinase C activation is
required for cigarette
Product Information Sheet - G1660
identification of acetylcholinesterase inhibitors
from natural products. J. Chromatogr. A, 872(1-2),
61-73 (2000).
GCY/RXR 10/03
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-Aldrich
1/13